CoChat

CNTN5-/+or EHMT2-/+human iPSC-derived neurons from individuals with autism develop hyperactive neuronal networks

Open access
Deneault, Eric, Faheem, Muhammad, White, Sean H, Rodrigues, Deivid C, Sun, Song, Wei, Wei, Piekna, Alina, Thompson, Tadeo, Howe, Jennifer L, Chalil, Leon, Kwan, Vickie, Walker, Susan, Pasceri, Peter, Roth, Frederick P, Yuen, Ryan KC, Singh, Karun K, Ellis, James, Scherer, Stephen W · 2019 · eLife

Published version of a preprint

Cited by 94

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Induced pluripotent stem cell (iPSC)-derived neurons are increasingly used to model Autism Spectrum Disorder (ASD), which is clinically and genetically heterogeneous. To study the complex relationship of penetrant and weaker polygenic risk variants to ASD, ‘isogenic’ iPSC-derived neurons are critical. We developed a set of procedures to control for heterogeneity in reprogramming and differentiation, and generated 53 different iPSC-derived glutamatergic neuronal lines from 25 participants from 12 unrelated families with ASD. Heterozygous de novo and rare-inherited presumed-damaging variants were characterized in ASD risk genes/loci. Combinations of putative etiologic variants (GLI3/KIF21A or EHMT2/UBE2I) in separate families were modeled. We used a multi-electrode array, with patch-clamp recordings, to determine a reproducible synaptic phenotype in 25% of the individuals with ASD (other relevant data on the remaining lines was collected). Our most compelling new results revealed a consistent spontaneous network hyperactivity in neurons deficient for CNTN5 or EHMT2. The biobank of iPSC-derived neurons and accompanying genomic data are available to accelerate ASD research. Editorial note: This article has been through an editorial process in which authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that all the issues have been addressed (see decision letter).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.40092

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 44

  1. Beltrão-Braga, 2017, Modeling autism spectrum disorders with human neurons, Brain Research, 1656, 49, 10.1016/j.brainres.2016.01.057 · DOI
  2. Betancur, 2011, Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting, Brain Research, 1380, 42, 10.1016/j.brainres.2010.11.078 · DOI · Paper page
  3. Canitano, 2017, Autism spectrum disorders and schizophrenia spectrum disorders: excitation/Inhibition imbalance and developmental trajectories, Frontiers in Psychiatry, 8, 10.3389/fpsyt.2017.00069 · DOI · Paper page
  4. Carter, 2013, Autism spectrum disorder in the genetics clinic: a review, Clinical Genetics, 83, 399, 10.1111/cge.12101 · DOI · Paper page
  5. Cheng, 2017, Highly expandable human iPS Cell-Derived neural progenitor cells (NPC) and neurons for central nervous system disease modeling and High-Throughput screening, Current Protocols in Human Genetics, 92, 8, 10.1002/cphg.33 · DOI · Paper page
  6. Deimling, 2017, The expanding role of the Ehmt2/G9a complex in neurodevelopment, Neurogenesis, 4, 10.1080/23262133.2017.1316888 · DOI
  7. Devlin, 2012, Genetic architecture in autism spectrum disorder, Current Opinion in Genetics & Development, 22, 229, 10.1016/j.gde.2012.03.002 · DOI · Paper page
  8. Dodé, 2009, Kallmann syndrome, European Journal of Human Genetics, 17, 139, 10.1038/ejhg.2008.206 · DOI · Paper page
  9. Dolmetsch, 2011, The human brain in a dish: the promise of iPSC-derived neurons, Cell, 145, 831, 10.1016/j.cell.2011.05.034 · DOI · Paper page
  10. DSM-5, 2013, Diagnostic and Statistical Manual of Mental Disorders, 10.1176/appi.books.9780890425596 · DOI · Paper page
  11. Durak, 2014, Human induced pluripotent stem cells: now open to discovery, Cell Stem Cell, 15, 4, 10.1016/j.stem.2014.06.014 · DOI
  12. Fernandez, 2017, Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach, Dialogues in Clinical Neuroscience, 19, 353, 10.31887/DCNS.2017.19.4/sscherer · DOI · Paper page
  13. Geschwind, 2015, Gene hunting in autism spectrum disorder: on the path to precision medicine, The Lancet Neurology, 14, 1109, 10.1016/S1474-4422(15)00044-7 · DOI · Paper page
  14. Habela, 2016, Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons, Molecular and Cellular Neuroscience, 73, 52, 10.1016/j.mcn.2015.12.002 · DOI · Paper page
  15. Ho, 2016, Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells, Methods, 101, 113, 10.1016/j.ymeth.2015.11.019 · DOI · Paper page
  16. Hoang, 2018, Communicating complex genomic information: a counselling approach derived from research experience with autism spectrum disorder, Patient Education and Counseling, 101, 352, 10.1016/j.pec.2017.07.029 · DOI
  17. Hoffman, 2019, New considerations for hiPSC-based models of neuropsychiatric disorders, Molecular Psychiatry, 24, 49, 10.1038/s41380-018-0029-1 · DOI · Paper page
  18. Hotta, 2009, Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency, Nature Methods, 6, 370, 10.1038/nmeth.1325 · DOI · Paper page
  19. Jiang, 2013, Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing, The American Journal of Human Genetics, 93, 249, 10.1016/j.ajhg.2013.06.012 · DOI · Paper page
  20. Jinek, 2012, A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science, 337, 816, 10.1126/science.1225829 · DOI · Paper page
  21. Karmacharya, 2016, Stem cell models of neuropsychiatric disorders, Molecular and Cellular Neuroscience, 73, 1, 10.1016/j.mcn.2016.03.007 · doi:10.1016/j.mcn.2016.03.007
  22. Kim, 2011, Isolation and culture of neurons and astrocytes from the mouse brain cortex, Methods in Molecular Biology, 793, 63, 10.1007/978-1-61779-328-8_4 · DOI · Paper page
  23. Kleefstra, 2005, Disruption of the gene euchromatin histone methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome, Journal of Medical Genetics, 42, 299, 10.1136/jmg.2004.028464 · DOI · Paper page
  24. Lionel, 2011, Rare copy number variation discovery and Cross-Disorder comparisons identify risk genes for ADHD, Science Translational Medicine, 3, 10.1126/scitranslmed.3002464 · DOI · Paper page
  25. Mahdi, 2018, An international clinical study of ability and disability in autism spectrum disorder using the WHO-ICF framework, Journal of Autism and Developmental Disorders, 48, 2148, 10.1007/s10803-018-3482-4 · DOI
  26. Manara, 2014, Brain changes in Kallmann syndrome, American Journal of Neuroradiology, 35, 1700, 10.3174/ajnr.A3946 · DOI
  27. Mercati, 2017, CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders, Molecular Psychiatry, 22, 625, 10.1038/mp.2016.61 · DOI · Paper page
  28. Miyaoka, 2014, Isolation of single-base genome-edited human iPS cells without antibiotic selection, Nature Methods, 11, 291, 10.1038/nmeth.2840 · DOI · Paper page
  29. Otto, 1996, Quantitative detection of cell culture mycoplasmas by a one step polymerase chain reaction method, Methods in Cell Science, 18, 261, 10.1007/BF00127903 · DOI
  30. Pak, 2015, Human neuropsychiatric disease modeling using conditional deletion reveals synaptic transmission defects caused by heterozygous mutations in NRXN1, Cell Stem Cell, 17, 316, 10.1016/j.stem.2015.07.017 · DOI · Paper page
  31. Powell, 2017, Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease, Molecular and Cellular Neuroscience, 82, 157, 10.1016/j.mcn.2017.05.007 · DOI
  32. Rice, 2003, Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains, Molecular Cell, 12, 1591, 10.1016/S1097-2765(03)00479-9 · DOI · Paper page
  33. Roybon, 2010, GABAergic differentiation induced by Mash1 is compromised by the bHLH proteins Neurogenin2, NeuroD1, and NeuroD2, Cerebral Cortex, 20, 1234, 10.1093/cercor/bhp187 · DOI · Paper page
  34. Sun, 2016, An extended set of yeast-based functional assays accurately identifies human disease mutations, Genome Research, 26, 670, 10.1101/gr.192526.115 · DOI · Paper page
  35. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  36. Tukker, 2018, Human iPSC-derived neuronal models for in vitro neurotoxicity assessment, NeuroToxicology, 67, 215, 10.1016/j.neuro.2018.06.007 · DOI · Paper page
  37. van Daalen, 2011, Social responsiveness Scale-aided analysis of the clinical impact of copy number variations in autism, Neurogenetics, 12, 315, 10.1007/s10048-011-0297-2 · DOI · Paper page
  38. Winden, 2018, Abnormal mTOR activation in autism, Annual Review of Neuroscience, 41, 1, 10.1146/annurev-neuro-080317-061747 · DOI · Paper page
  39. Woodbury-Smith, 2017, Mutations in RAB39B in individuals with intellectual disability, autism spectrum disorder, and macrocephaly, Molecular Autism, 8, 10.1186/s13229-017-0175-3 · DOI
  40. Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
  41. Zhang, 2002, Structure of the neurospora SET domain protein DIM-5, a histone H3 lysine methyltransferase, Cell, 111, 117, 10.1016/S0092-8674(02)00999-6 · DOI · Paper page
  42. Zhang, 2003, Structural basis for the product specificity of histone lysine methyltransferases, Molecular Cell, 12, 177, 10.1016/S1097-2765(03)00224-7 · DOI · Paper page
  43. Zhang, 2017, Assessing predictions of fitness effects of missense mutations in SUMO-conjugating enzyme UBE2I, Human Mutation, 38, 1051, 10.1002/humu.23293 · DOI
  44. Zylicz, 2015, Chromatin dynamics and the role of G9a in gene regulation and enhancer silencing during early mouse development, eLife, 4, 10.7554/eLife.09571 · DOI · Paper page

Cited by

See all 94

Metadata

Authors
Deneault, E., Faheem, M., White, S. H., Rodrigues, D. C., Sun, S., Wei, W., Piekna, A., Thompson, T., Howe, J. L., Chalil, L., Kwan, V., Walker, S., Pasceri, P., Roth, F. P., Yuen, R. K., Singh, K. K., Ellis, J., & Scherer, S. W.
Venue
eLife
Published
2019-02-12
Volume
8
ISSN
2050-084X (ISSN-L)
OpenAlex
W2952831623
Cited by
94
References
27
FWCI
6.62
Type
journal article
Language
en
Open access
gold
Funders
  • Canadian Institutes of Health Research
  • Canadian Institute for Advanced Research
  • Canada Foundation for Innovation
  • National Institutes of Health
  • Ontario Brain Institute
  • Natural Sciences and Engineering Research Council of Canada
  • Province of Ontario Neurodevelopmental Disorders
  • Ontario Research Fund
  • Genome Canada
  • University of Toronto McLaughlin Centre
  • Autism Speaks
  • Hospital for Sick Children

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CNTN5-/+or EHMT2-/+human iPSC-derived neurons from individuals with autism develop hyperactive neuronal networks. https://app.cochat.ai/papers/10.7554/elife.40092
The paper
Deneault, E., Faheem, M., White, S. H., Rodrigues, D. C., Sun, S., Wei, W., Piekna, A., Thompson, T., Howe, J. L., Chalil, L., Kwan, V., Walker, S., Pasceri, P., Roth, F. P., Yuen, R. K., Singh, K. K., Ellis, J., & Scherer, S. W. (2019). CNTN5-/+or EHMT2-/+human iPSC-derived neurons from individuals with autism develop hyperactive neuronal networks. eLife. https://doi.org/10.7554/elife.40092

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.